mTOR Signalling in Head and Neck Cancer: Heads Up

mTOR Signalling in Head and Neck Cancer: Heads Up

The mammalian target of rapamycin (mTOR) signalling pathway is a central regulator of metabolism in all cells. It senses intracellular and extracellular signals and nutrient levels, and coordinates the metabolic requirements for cell growth, survival, and proliferation. Genetic alterations that dere...

Full description

Bibliographic Details
Main Authors:	Fiona H. Tan, Yuchen Bai, Pierre Saintigny, Charbel Darido
Format:	Article
Language:	English
Published:	MDPI AG 2019-04-01
Series:	Cells
Subjects:	mTOR signalling metabolism head and neck cancer mutant genes biomarkers targeted therapies clinical trials
Online Access:	https://www.mdpi.com/2073-4409/8/4/333

Similar Items

Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study
by: Diane Evrard, et al.
Published: (2022-09-01)

Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas
by: Yu-Chieh Su, et al.
Published: (2022-12-01)

Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
by: Ming-Huei Chou, et al.
Published: (2021-03-01)

Expression of mTOR in normal and pathological conditions
by: A Marques-Ramos, et al.
Published: (2023-07-01)

Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?
by: Jens von der Grün, et al.
Published: (2019-04-01)

Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
by: James T. Murray, et al.
Published: (2018-05-01)

Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
by: Aleksandra Derwich, et al.
Published: (2023-03-01)

Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review
by: Hajar Alammar, et al.
Published: (2021-12-01)

Targeting the PI3K/Akt/mTOR Signaling Pathway: Applications of Nanotechnology
by: Forough Alemi Serej, et al.
Published: (2018-01-01)

Medical Aspects of mTOR Inhibition in Kidney Transplantation
by: Elena Cuadrado-Payán, et al.
Published: (2022-07-01)

In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease
by: Alysia Cox, et al.
Published: (2023-08-01)

Head and neck /
by: Brandwein-Gensler, Margaret
Published: (2010)

The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects
by: Eleni A. Karatrasoglou, et al.
Published: (2023-09-01)

mTOR Pathways in Cancer and Autophagy
by: Mathieu Paquette, et al.
Published: (2018-01-01)

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
by: Zhang Yang, et al.
Published: (2022-01-01)

Modulation of the mTOR Pathway by Curcumin in the Heart of Septic Mice
by: Bruna A. C. Rattis, et al.
Published: (2022-10-01)

Rasgrp1 mutation increases naïve T-cell CD44 expression and drives mTOR-dependent accumulation of Helios+ T cells and autoantibodies
by: Stephen R Daley, et al.
Published: (2013-12-01)

Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy
by: Abdelhakim Bouyahya, et al.
Published: (2022-11-01)

mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership
by: Angel Cayo, et al.
Published: (2021-07-01)

The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
by: Letizia Todeschini, et al.
Published: (2023-06-01)

Targeting mTOR in Acute Lymphoblastic Leukemia
by: Carolina Simioni, et al.
Published: (2019-02-01)

Head and neck [electronic resource] /
by: Brandwein-Gensler, Margaret
Published: (2010)

Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma
by: Luca Felkai, et al.
Published: (2020-07-01)

Advances in the regulatory mechanisms of mTOR in necroptosis
by: Yawen Xie, et al.
Published: (2023-12-01)

The mTOR Signalling Pathway in Human Cancer
by: Paula Soares, et al.
Published: (2012-02-01)

Head and neck radiology /
by: Mancuso, Anthony A., et al.
Published: (c201)

Mcminn's color atlas of head and neck anatomy /
by: 394434 Logan, Bari M, et al.
Published: (2010)

Targeting the mTOR Signaling Pathway Utilizing Nanoparticles: A Critical Overview
by: Mariia Lunova, et al.
Published: (2019-01-01)

Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
by: Alexandre el Hage, et al.
Published: (2021-03-01)

Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
by: Farzaneh Kordbacheh, et al.
Published: (2021-10-01)

Recent advances and limitations of mTOR inhibitors in the treatment of cancer
by: Eunus S. Ali, et al.
Published: (2022-09-01)

Head & neck cancer : current perspectives, advances, and challenges /
by: Radosevich, James A. (James Andrew)
Published: (c201)

Stell & Maran's textbook of head and neck surgery and oncology
by: Watkinson, John C., et al.
Published: (2012)

Gorlin's syndromes of the head and neck /
by: 521434 Hennekam, Raoul C. M., et al.
Published: (c201)

Textbook of head and neck anatomy /
by: Hiatt, James L., 1934-, et al.
Published: (c201)

Diagnostic imaging : head and neck /
by: Harnsberger, H. Ric
Published: (c201)

Biphasic regulation of osteoblast development via the ERK MAPK–mTOR pathway
by: Jung-Min Kim, et al.
Published: (2022-08-01)

The difficult case in head and neck cancer surgery /
by: 515607 Donald, Paul J.
Published: (c201)

Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer
by: Suhail Ahmad Mir, et al.
Published: (2023-07-01)